Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Gains 8%; BSE HEALTHCARE Index Up 1.1%
Thu, 31 Oct 9:26

Cipla Gains 8%; BSE HEALTHCARE Index Up 1.1%Image source: alexsl/www.istockphoto.com

Cipla share price has zoomed 8% and is presently trading at Rs 1,532.0.

Meanwhile, the BSE HEALTHCARE index is at 43,590.7 (up 1.1%).

Among the top gainers in the BSE HEALTHCARE index today are AJANTA PHARMA (up 2.9%) and POLY MEDICURE (up 2.4%).

Biocon (down 2.3%) and ASTRAZENECA PHARMA (down 0.7%) are among the top losers today.

Over the last one year, Cipla has moved up from Rs 1,193.1 to Rs 1,532.0, registering a gain of Rs 339.0 (up 28.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,385.2 to 43,590.7, registering a gain of 59.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 195.2%), SUVEN PHARMACEUTICALS (up 127.2%) and Glenmark Pharma (up 124.8%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,820.3 (down 0.2%).

The top losers among the BSE Sensex today are Tech Mahindra (down 1.9%) and Infosys (down 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,293.5 (down 0.2%). Tech Mahindra and Infosys are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,112.7 to 79,820.3, registering a gain of 15,707.7 points (up 24.5%).

Cipla Financial Update...

Cipla net profit grew 13.0% YoY to Rs 13,060 million for the quarter ended September 2024, compared to a profit of Rs 11,558 million a year ago. Net sales rose 5.6% to Rs 70,510 million during the period as against Rs 66,782 million in July-September 2023.

For the year ended March 2024, Cipla reported 46.5% increase in net profit to Rs 41,553 million compared to net profit of Rs 28,355 million during FY23. Revenue of the company grew 13.3% to Rs 257,741 million during FY24.

The current Price to earnings ratio of Cipla, based on rolling 12 month earnings, stands at 27.6.


Equitymaster requests your view! Post a comment on "Cipla Gains 8%; BSE HEALTHCARE Index Up 1.1%". Click here!